These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3250051)

  • 61. [Feedback of the magnesium ion on the parathyroid hormone: differences in the action of magnesium sulfate and pyrrolidone carboxylate].
    Ferment O; Garnier PE; Touitou Y
    Pathol Biol (Paris); 1986 Oct; 34(8):951-4. PubMed ID: 3537940
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Use of magnesium pyrrolidonecarboxylic acid in uterine dyskinesia].
    Puech F; Delecour M
    Lille Med; 1976 Sep; 21(7 Suppl 3):602-5. PubMed ID: 994689
    [No Abstract]   [Full Text] [Related]  

  • 63. Inhibitory effect of L-pyroglutamate on extremophiles: correlation with growth temperature and pH.
    Park CB; Ryu DD; Lee SB
    FEMS Microbiol Lett; 2003 Apr; 221(2):187-90. PubMed ID: 12725925
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Synthesis of pyrrolidonecarboxylic acid (PCA). Report].
    Jacórzyński B
    Rocz Panstw Zakl Hig; 1972; 23(1):73-5. PubMed ID: 5031465
    [No Abstract]   [Full Text] [Related]  

  • 65. Pyroglutamic acid improves learning and memory capacities in old rats.
    Drago F; Valerio C; D'Agata V; Astuto C; Spadaro F; Continella G; Scapagnini U
    Funct Neurol; 1988; 3(2):137-43. PubMed ID: 3402813
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pyroglutamyl diazomethyl ketone: potent inhibitor of mammalian pyroglutamyl peptide hydrolase.
    Wilk S; Friedman TC; Kline TB
    Biochem Biophys Res Commun; 1985 Jul; 130(2):662-8. PubMed ID: 2862865
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sodium-coupled electrogenic transport of pyroglutamate (5-oxoproline) via SLC5A8, a monocarboxylate transporter.
    Miyauchi S; Gopal E; Babu E; Srinivas SR; Kubo Y; Umapathy NS; Thakkar SV; Ganapathy V; Prasad PD
    Biochim Biophys Acta; 2010 Jun; 1798(6):1164-71. PubMed ID: 20211600
    [TBL] [Abstract][Full Text] [Related]  

  • 68. L-pyroglutamate: an alternate neurotoxin for a rodent model of Huntington's disease.
    Rieke GK; Scarfe AD; Hunter JF
    Brain Res Bull; 1984 Sep; 13(3):443-56. PubMed ID: 6238648
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Biosynthesis of pyrrolidone carboxylic acid in hairless mouse epidermis.
    DeLapp NW; Dieckman DK
    J Invest Dermatol; 1977 May; 68(5):293-8. PubMed ID: 870563
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The use of FAB mass spectrometry and pyroglutamate aminopeptidase digestion for the structure determination of pyroglutamate in modified peptides.
    Kim J; Kim K
    Biochem Mol Biol Int; 1995 Apr; 35(4):803-11. PubMed ID: 7627130
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Is glutamic acid the pyramidal tract neurotransmitter?
    Stone TW
    Experientia; 1976 May; 32(5):581-3. PubMed ID: 6297
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Diastereoselective synthesis of glutamate-appended oxolane rings: synthesis of (s)-(+)-lycoperdic acid.
    Cohen JL; Chamberlin AR
    J Org Chem; 2007 Nov; 72(24):9240-7. PubMed ID: 17975930
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pyrrolidone carboxylic acid (pyroglutamic acid) in normal plasma.
    Wolfersberger MG; Tabachnik J
    Experientia; 1973 Mar; 29(3):346-7. PubMed ID: 4708727
    [No Abstract]   [Full Text] [Related]  

  • 74. Pyrrolidone carboxylic acid in acute and chronic alcoholism. Preclinical and clinical studies.
    Pellegrini-Giampietro DE; Moroni F; Pistelli A; Palmerani B; Zorn AM; Peruzzi S; Caramelli L; Botti P; Valenza T; Antonini M
    Recenti Prog Med; 1989 Mar; 80(3):160-4. PubMed ID: 2740606
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Chemical method for identification of N-blocked group in pyroglutamic acid peptides.
    Gupta S; Sharma K; Narang CK; Mathur NK
    Indian J Biochem Biophys; 1984 Apr; 21(2):133-4. PubMed ID: 6490073
    [No Abstract]   [Full Text] [Related]  

  • 76. FR-900148, a new antibiotic. I. Taxonomy, fermentation, isolation and characterization.
    Kuroda Y; Okuhara M; Goto T; Yamashita M; Iguchi E; Kohsaka M; Aoki H; Imanaka H
    J Antibiot (Tokyo); 1980 Mar; 33(3):259-66. PubMed ID: 6897940
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synthesis and angiotensin-converting enzyme inhibitory activity of 3-(Mercaptomethyl)-2-oxo-1-pyrrolidineacetic acids and 3-(Mercaptomethyl)-2-oxo-1-piperidineacetic acids.
    Klutchko S; Hoefle ML; Smith RD; Essenburg AD; Parker RB; Nemeth VL; Ryan MJ; Dugan DH; Kaplan HR
    J Med Chem; 1981 Jan; 24(1):104-9. PubMed ID: 6259352
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Accumulation of pyroglutamic acid (5-oxoproline) in homocystinuria.
    Stokke O; Marstein S; Jellum E; Lie SO
    Scand J Clin Lab Invest; 1982 Jun; 42(4):361-9. PubMed ID: 7134819
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Demonstration of a pyroglutamyl residue at the N terminus of the B-chain of porcine relaxin.
    Schwabe C; McDonald JK
    Biochem Biophys Res Commun; 1977 Feb; 74(4):1501-4. PubMed ID: 843375
    [No Abstract]   [Full Text] [Related]  

  • 80. The occurrence of neurotoxic pyroglutamic acid in parenteral amino acid solutions. Specific determination by means of capillary isotachophoresis.
    Stehle P; Fürst P
    Clin Chim Acta; 1987 Nov; 169(2-3):323-7. PubMed ID: 3123102
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.